EMA re­views da­ta on risk of neu­rode­vel­op­men­tal dis­or­ders for chil­dren with fa­thers on val­proate drugs

The Eu­ro­pean Med­i­cines Agency said this week that it’s look­ing in­to da­ta — ret­ro­spec­tive ob­ser­va­tion­al da­ta that need to be cor­rect­ed by the com­pa­ny that ran …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER